These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 20054744

  • 1. Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis?
    Ashtari F, Fatehi F, Shaygannejad V, Chitsaz A.
    Neurol Neurochir Pol; 2009; 43(5):428-32. PubMed ID: 20054744
    [Abstract] [Full Text] [Related]

  • 2. Amantadine and the place of acupuncture in the treatment of fatigue in patients with multiple sclerosis: an observational study.
    Foroughipour M, Bahrami Taghanaki HR, Saeidi M, Khazaei M, Sasannezhad P, Shoeibi A.
    Acupunct Med; 2013 Mar; 31(1):27-30. PubMed ID: 23151355
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study.
    Shaygannejad V, Janghorbani M, Ashtari F, Zakeri H.
    Neurol Res; 2012 Nov; 34(9):854-8. PubMed ID: 22979982
    [Abstract] [Full Text] [Related]

  • 4. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.
    Nourbakhsh B, Revirajan N, Morris B, Cordano C, Creasman J, Manguinao M, Krysko K, Rutatangwa A, Auvray C, Aljarallah S, Jin C, Mowry E, McCulloch C, Waubant E.
    Lancet Neurol; 2021 Jan; 20(1):38-48. PubMed ID: 33242419
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
    Tomassini V, Pozzilli C, Onesti E, Pasqualetti P, Marinelli F, Pisani A, Fieschi C.
    J Neurol Sci; 2004 Mar 15; 218(1-2):103-8. PubMed ID: 14759641
    [Abstract] [Full Text] [Related]

  • 6. Amantadine influences cognitive processing in patients with multiple sclerosis.
    Sailer M, Heinze HJ, Schoenfeld MA, Hauser U, Smid HG.
    Pharmacopsychiatry; 2000 Jan 15; 33(1):28-37. PubMed ID: 10721881
    [Abstract] [Full Text] [Related]

  • 7. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo.
    Krupp LB, Coyle PK, Doscher C, Miller A, Cross AH, Jandorf L, Halper J, Johnson B, Morgante L, Grimson R.
    Neurology; 1995 Nov 15; 45(11):1956-61. PubMed ID: 7501140
    [Abstract] [Full Text] [Related]

  • 8. Evaluating the effects of amantadin, modafinil and acetyl-L-carnitine on fatigue in multiple sclerosis--result of a pilot randomized, blind study.
    Ledinek AH, Sajko MC, Rot U.
    Clin Neurol Neurosurg; 2013 Dec 15; 115 Suppl 1():S86-9. PubMed ID: 24321164
    [Abstract] [Full Text] [Related]

  • 9. Validity and reliability of Persian version of Modified Fatigue Impact Scale (MFIS) questionnaire in Iranian patients with multiple sclerosis.
    Ghajarzadeh M, Jalilian R, Eskandari G, Ali Sahraian M, Reza Azimi A.
    Disabil Rehabil; 2013 Aug 15; 35(18):1509-12. PubMed ID: 23237227
    [Abstract] [Full Text] [Related]

  • 10. Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study.
    Zifko UA, Rupp M, Schwarz S, Zipko HT, Maida EM.
    J Neurol; 2002 Aug 15; 249(8):983-7. PubMed ID: 12195441
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis.
    Yang TT, Wang L, Deng XY, Yu G.
    J Neurol Sci; 2017 Sep 15; 380():256-261. PubMed ID: 28870581
    [Abstract] [Full Text] [Related]

  • 12. HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis.
    Möller F, Poettgen J, Broemel F, Neuhaus A, Daumer M, Heesen C.
    Mult Scler; 2011 Aug 15; 17(8):1002-9. PubMed ID: 21561959
    [Abstract] [Full Text] [Related]

  • 13. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
    Stankoff B, Waubant E, Confavreux C, Edan G, Debouverie M, Rumbach L, Moreau T, Pelletier J, Lubetzki C, Clanet M, French Modafinil Study Group.
    Neurology; 2005 Apr 12; 64(7):1139-43. PubMed ID: 15824337
    [Abstract] [Full Text] [Related]

  • 14. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
    Nourbakhsh B, Revirajan N, Waubant E.
    Contemp Clin Trials; 2018 Jan 12; 64():67-76. PubMed ID: 29113955
    [Abstract] [Full Text] [Related]

  • 15. MSQoL-54 predicts change in fatigue after inpatient rehabilitation for people with multiple sclerosis.
    Drulovic J, Bursac LO, Milojkovic D, Tepavcevic DK, Gazibara T, Pekmezovic T.
    Disabil Rehabil; 2013 Mar 12; 35(5):362-6. PubMed ID: 22897503
    [Abstract] [Full Text] [Related]

  • 16. The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis.
    Geisler MW, Sliwinski M, Coyle PK, Masur DM, Doscher C, Krupp LB.
    Arch Neurol; 1996 Feb 12; 53(2):185-8. PubMed ID: 8639070
    [Abstract] [Full Text] [Related]

  • 17. The effect of Ginkgo biloba on functional measures in multiple sclerosis: a pilot randomized controlled trial.
    Johnson SK, Diamond BJ, Rausch S, Kaufman M, Shiflett SC, Graves L.
    Explore (NY); 2006 Jan 12; 2(1):19-24. PubMed ID: 16781604
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.
    Cohen JA, Hunter SF, Brown TR, Gudesblatt M, Thrower BW, Llorens L, Souza-Prien CJ, Ruby AE, Chernoff DN, Patni R.
    Mult Scler; 2019 Apr 12; 25(4):601-609. PubMed ID: 29368539
    [Abstract] [Full Text] [Related]

  • 19. Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial.
    Sanoobar M, Dehghan P, Khalili M, Azimi A, Seifar F.
    Nutr Neurosci; 2016 Apr 12; 19(3):138-43. PubMed ID: 25603363
    [Abstract] [Full Text] [Related]

  • 20. Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
    Brañas P, Jordan R, Fry-Smith A, Burls A, Hyde C.
    Health Technol Assess; 2000 Apr 12; 4(27):1-61. PubMed ID: 11074395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.